Food And Drug Administration-Healthday News-Breast Cancer

Perjeta Approved for Advanced Breast Cancer

MONDAY, June 11 (Healthday News) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release. read more..

source:http://yhoo.it/LG1Fp1